ARTICLE | Clinical News
Toraymyxin: Ph III EUPHRATES data
January 6, 2017 10:32 PM UTC
Last October, Spectral reported top-line data from the double-blind, North American Phase III EUPHRATES trial in 450 patients with endotoxemic septic shock showing that 2 columns of Toraymyxin plus st...
BCIQ Company Profiles